Biotech

All Articles

Gene publisher Volume laying off 131 laborers

.Simply times after genetics publisher Tome Biosciences introduced hidden operational cuts, a more c...

Repare gives up 25% of personnel as biotech halts preclinical R&ampD

.Repare Therapy is giving up a quarter of its workforce as the oncology biotech scales back its own ...

J &amp J declare FDA approval of $6.5 B autoimmune drug

.Johnson &amp Johnson has gotten another measure toward noticing a profit on its $6.5 billion nipoca...

Gain's stage 1 succeed paves means to prove Parkinson's medicine's worth

.Increase Therapies has specified its own sights on proving the performance of its Parkinson's healt...

Actinogen files brand new period 2 information to recover anxiety medicine

.Actinogen Medical's chances-- as well as stock rate-- have rebounded somewhat coming from previousl...

Pfizer and Flagship incorporate Ratio to multibillion-dollar formula

.Front Runner Pioneering and also Pfizer have included Quotient into their 10-program collaboration,...

Bayer pens $547M treaty to press boundaries of noncoding RNA

.Bayer managers were actually keen to tension to Fierce this summertime that the German pharma giant...

UK unveils plans to introduce 18 brand new medical trial centers

.Among a yearslong clinical trial decline in the U.K., a brand-new public-private partnership has ac...

UPDATE: Genentech telegraphs 93 discharges in The golden state after sharing programs to shutter cancer cells immunology analysis unit

.Adhering to the news of a sizable discharge round in April and a major restructuring project introd...

Neurocrine's KarXT rival strikes in stage 2-- but just at reduced dose

.Neurocrine Biosciences has achieved its own hoped-for profile page in a period 2 schizophrenia tria...